IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-0-387-30107-5_21.html
   My bibliography  Save this book chapter

Monitoring a Clinical Trial With Waiver of Informed Consent: Diaspirin Cross-Linked Hemoglobin for Emergency Treatment of Post—Traumatic Shock

In: Data Monitoring in Clinical Trials

Author

Listed:
  • Roger J. Lewis

    (Harbor-UCLA Medical Center, Department of Emergency Medicine
    UCLA School of Medicine
    Los Angeles Biomedical Research Institute)

  • Norman Fost

    (University of Wisconsin, Departments of Pediatrics and Medical History and Bioethics)

Abstract

In 1996, the FDA and DHHS regulations were modified to allow randomized controlled trials in emergency settings with a waiver of informed consent (from patients or surrogates) under specified conditions. The first large multi-center trial under the new regulations was sponsored by Baxter Laboratories, comparing a semi-synthetic hemoglobin to standard care in the initial resuscitation of adults presenting with post-hemorrhagic shock. In addition to the familiar problems that the Data Monitoring Committee had to face, there were new issues, such as reviewing procedures for community disclosure and community consultation, and a heightened sense of scrutiny because of the waiver of traditional consent. The trial was terminated because of higher than expected mortality in the group receiving the experimental treatment. The number of trials initiated under the regulations seems to be less than anticipated, perhaps because the regulatory burden is seens as too onerous.

Suggested Citation

  • Roger J. Lewis & Norman Fost, 2006. "Monitoring a Clinical Trial With Waiver of Informed Consent: Diaspirin Cross-Linked Hemoglobin for Emergency Treatment of Post—Traumatic Shock," Springer Books, in: David L. DeMets & Curt D. Furberg & Lawrence M. Friedman (ed.), Data Monitoring in Clinical Trials, chapter 0, pages 228-235, Springer.
    • Handle: RePEc:spr:sprchp:978-0-387-30107-5_21
    DOI: 10.1007/0-387-30107-0_21
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-0-387-30107-5_21. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.